Delivery Order SPE2DX22D0010-SPE2D826FAK77

The Department of Defense's Medical Supply Chain awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Nucynta ER Tabs 200mg, a controlled-release opioid pain management pharmaceutical. The contract, awarded on October 16, 2025, with an ultimate completion date of October 17, 2025, carries a ceiling value of $2,186.26 and utilizes firm fixed pricing with no set-aside designation. This delivery order represents a competitive award issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The prime contractor, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor supporting military and veteran healthcare systems across multiple therapeutic domains.

AmerisourceBergen Drug Corp's substantial IDC with DLA Troop Support Medical functions as a comprehensive global pharmaceutical support vehicle enabling the delivery of brand-name and generic medications, vaccines, specialty drugs, and medical supplies to support Defense Health Agency operations and other federal healthcare systems worldwide. The company's demonstrated capability to fulfill federal procurement requirements through open competition, evidenced by numerous competitively awarded contracts ranging from small-value transactions to orders exceeding $45,000, positions it as a key vendor for the military's pharmaceutical procurement needs. The company is also positioned as a potential contractor for the Defense Logistics Agency's planned Pharmaceutical Prime Vendor Global Program Generation V initiative, which is expected to establish multiple regional contracts with separate contractors.